Follow
Kirit Singh, MBBS, MSc.
Kirit Singh, MBBS, MSc.
Sampson Lab, Duke University
Verified email at duke.edu - Homepage
Title
Cited by
Cited by
Year
Targeting immunometabolism in glioblastoma
AA Mohan, WH Tomaszewski, AP Haskell-Mendoza, KM Hotchkiss, ...
Frontiers in Oncology 11, 696402, 2021
242021
Designing clinical trials for combination immunotherapy: a framework for glioblastoma
K Singh, KA Batich, PY Wen, AC Tan, SJ Bagley, M Lim, M Platten, ...
Clinical Cancer Research 28 (4), 585-593, 2022
182022
Enhancing T cell chemotaxis and infiltration in glioblastoma
K Singh, KM Hotchkiss, KK Patel, DS Wilkinson, AA Mohan, SL Cook, ...
Cancers 13 (21), 5367, 2021
182021
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
K Singh, KM Hotchkiss, IF Parney, J De Groot, S Sahebjam, N Sanai, ...
Nature medicine 29 (10), 2402-2405, 2023
132023
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
K Singh, KM Hotchkiss, AA Mohan, JL Reedy, JH Sampson, M Khasraw
Journal for Immunotherapy of Cancer 9 (11), 2021
112021
Improving access to Early Intervention in Psychosis (EIP): the 2-week wait for cancer comes to psychosis
K Singh, F Ghazi, R White, B Sarfo-Adu, P Carter
BMJ Open Quality 7 (3), e000190, 2018
92018
Xanthomatous hypophysitis causing hypogonadotropic hypogonadism resulting in delayed presentation of slipped capital femoral epiphysis
K Singh, AK Kanodia, P Ross, A Torgersen, J Maclean, G Leese, ...
British Journal of Neurosurgery 36 (2), 286-289, 2022
72022
Does time of surgery influence the rate of false-negative appendectomies? A retrospective observational study of 274 patients
K Singh, MSJ Wilson, M Coats
Patient safety in surgery 12, 1-6, 2018
52018
P01. 142 Comparing Outcomes in Glioblastoma Multiforme patients undergoing Photodynamic Therapy with a Second-Generation Photosensitiser vs 5-Aminolevulinic Acid-A Single Site …
K Singh, O Kouli, A Kanodia, C Goodman, E Eadie, S Ibbotson, ...
Neuro-Oncology 20 (suppl_3), iii265-iii265, 2018
42018
Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma
SE Zaidi, E Moelker, K Singh, A Mohan, MA Salgado, MA Essibayi, ...
BioDrugs 37 (4), 489-503, 2023
32023
Endovascular and surgical obliteration rates of spinal dural arteriovenous fistulae: a single UK Centre experience
K Singh, M Zaben, S Manivannan, J Van Beijnum, J Galea, G Zilani
British Journal of Neurosurgery 37 (6), 1613-1618, 2023
22023
Improving the surgical consenting process for patients with acute hip fractures: a pilot quality improvement project
K Singh, A Assaf, M Bayley, G Gillespie
Patient Safety in Surgery 14, 1-6, 2020
22020
An unusual case of a grade I meningioma with perineural spread
M Fadelalla, AK Kanodia, J Brunton, K Singh, A Torgersen, E Sammler, ...
British Journal of Neurosurgery 37 (4), 637-640, 2023
12023
IL-7 mediated upregulation of VLA-4 increases accumulation of adoptively transferred T lymphocytes in murine glioma.
K Singh, KM Hotchkiss, SL Cook, P Noldner, Y Zhou, EM Moelker, ...
bioRxiv, 2024.04. 01.587634, 2024
2024
DEVELOPING PATIENT SPECIFIC TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH INCREASED TUMOR SPECIFICITY AS A THERAPY FOR GLIOBLASTOMA
K Hotchkiss, E Blandford, P Noldner, Y Zhou, K Singh, A Patel, P Fecci, ...
NEURO-ONCOLOGY 25, 2023
2023
A SURGICAL WINDOW-OF-OPPORTUNITY CLINICAL TRIAL EVALUATING THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH GLIOMA
K Singh, K Hotchkiss, M Foster, C Railton, E Blandford, E Thomas, ...
NEURO-ONCOLOGY 25, 2023
2023
RTID-07. A RANDOMIZED WINDOW OF OPPORTUNITY TRIAL WITH DOSE ESCALATION TO EVALUATE FLUOXETINE AND TEMOZOLOMIDE IN GLIOMA
K Singh, C Railton, K Hotchkiss, J Herndon, K Peters, H Friedman, ...
Neuro-Oncology 25 (Supplement_5), v260-v260, 2023
2023
Systemic autologous lymphocyte transfer can enhance tumor-infiltrating lymphocyte infiltration in glioblastoma and license co-stimulatory immunotherapy
K Singh, KM Hotchkiss, E Moelker, GE Archer, JH Sampson, M Khasraw
Cancer Research 83 (7_Supplement), 4061-4061, 2023
2023
Developing non-exhausted tumor infiltrating lymphocytes (TILs) as a therapy for glioblastoma
KM Hotchkiss, P Noldner, K Singh, A Patel, P Fecci, S Antonia, BH Shaz, ...
Cancer Research 83 (7_Supplement), 3193-3193, 2023
2023
Drug testing: translating a novel immunotherapeutic from bench to bedside
K Singh, JH Sampson, PC Gedeon
Translational Surgery, 43-51, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20